Dora® (Desloratadine) Tablet: Each film-coated tablet contains Desloratadine INN 5 mg.
Dora® (Desloratadine) Syrup: Each 5 ml syrup contains Desloratadine INN 2.5 mg.
Dora® (Desloratadine) is a preparation of Desloratadine. Desloratadine is a long-acting tricyclic histamine antagonist with selective H1 receptor antagonist activity. It is a non-sedating antihistamine. Desloratadine has effects in the chronic inflammatory response to allergens and lacks effects on the QT interval of ECG unlike some other non-sedating antihistamines.
Allergic rhinitis: Dora® (Desloratadine) is indicated for the relief of nasal and non-nasal symptoms of allergic rhinitis (seasonal and perennial) in patients 2 years of age or older.
Chronic idiopathic urticarial: Dora® (Desloratadine) is indicated for the symptomatic relief of pruritus, reduction in the number of hives and size of hives, in patients with chronic idiopathic urticarial, 2 years of age or older.
As there are no food effects on the bioavailability.
Dora® (Desloratadine) may be taken without regard to meal.
Adult and adolescent over 12 years : 2 mg daily
6 to 11 years : 2.5 m daily
Child 2-5 years: 1.25 mg daily
In patients with liver and renal impairment: A starting dose of 5mg every other day based on pharmacokinetic data.
Dora® (Desloratadine) is contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to Loratadine.
Pregnancy: There are no adequate and well-controlled studies in pregnant woman. Because animal reproduction studies are not always predictive of human response . Desloratadine should be used in pregnancy only If clearly needed.
Lactation: Desloratadine passes into breast mild. Therefore, a decision should be made whether to discontinue nursing or to discontinue Desloratadine, taking into account the importance of the drug to the mother.
Desloratadine is generally well tolerated. However, dry mount, fatigue, somnolence and myalgia are commonly reported side-effects. Less common side-effects may include dizziness, headache and nausea, rarely rash, pruritus and urticarial may occur.
No clinically important drug interactions have been reported.
No clinically relevant adverse effects have been reported in case of over dosage. However, in the event of overdose, symptomatic and supportive treatment is recommended.
Should be used by the prescription of registered physician
Keep in a cool dry place and protect from light.
Keep out of the reach of children.
Dora® (Desloratadine) Tablet: Each box contains 5×10’s tablets in blister pack.
Dora® (Desloratadine) Syrup: 60ml Syrup in a amber glass bottle.